The US government and Gilead Sciences have announced a landmark plan to supply the long-acting HIV prevention drug, lenacapavir, at cost to high-burden countries. This initiative aims to protect 2 million people via PEPFAR and The Global Fund. In a major step forward for global public health, the United States State Department announced a groundbreaking plan on Thursday. The aim…